Literature DB >> 23461955

Lymph node ratio as a predictor of survival in gastric carcinoma.

Heriberto Medina-Franco1, Francisco Cabrera-Mendoza, Susana Almaguer-Rosales, Fabiola Guillén, Yoli L Suárez-Bobadilla, Ariadne Sánchez-Ramón.   

Abstract

According to the American Joint Committee on Cancer (AJCC), the number of metastatic lymph nodes is the main prognostic factor in gastric cancer. Lymph node ratio (LNR) has been proposed as a better predictor of survival. We included patients resected for gastric cancer in a referral center in Mexico City. Number of metastatic nodes was analyzed according to AJCC 2002 and 2010. We divided LNR into four stages. Survival was calculated with the Kaplan-Meier method and curves compared with the log-rank test. P < 0.05 was significant. Two hundred patients were included. Median number of retrieved and metastatic nodes were 18 and 2.5, respectively. Median survival was 44 months. AJCC 2010 was a better predictor of survival than the 2002 version (P < 0.001). Median survival for LNR 0, 1, 2, and 3 was 117, 68, 44, and 14 months, respectively (P < 0.001). In patients with less than 15 nodes removed, AJCC was not a predictor of survival (P = 0.09) but LNR was (P = 0.04). Nodal staging in AJCC 2010 is a better predictor of survival than the 2002 edition. LNR is useful in the group of patients with suboptimal node dissection.

Entities:  

Mesh:

Year:  2013        PMID: 23461955

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  9 in total

Review 1.  N staging system: tumor-node-metastasis and future perspectives.

Authors:  Federica Galli; Laura Ruspi; Alessandro Marzorati; Matteo Lavazza; Giuseppe Di Rocco; Luigi Boni; Gianlorenzo Dionigi; Stefano Rausei
Journal:  Transl Gastroenterol Hepatol       Date:  2017-01-17

2.  Three-step hand-assisted laparoscopic surgery for radical distal gastrectomy: an effective surgical approach.

Authors:  Jia-Qing Gong; Yong-Kuan Cao; Yong-Hua Wang; Guo-Hu Zhang; Pei-Hong Wang; Guo-De Luo
Journal:  Int J Clin Exp Med       Date:  2014-08-15

3.  Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.

Authors:  Christian Jacobi; Josepha Rauch; Jan Hagemann; Thomas Lautz; Maximilian Reiter; Philipp Baumeister
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-04       Impact factor: 2.503

4.  Preoperative predicting score of lymph node metastasis for gastric cancer.

Authors:  Yanjun Zhang; Zhi Zhu; Zhe Sun; Zhenning Wang; Xinyu Zheng; Huimian Xu
Journal:  Tumour Biol       Date:  2014-07-23

5.  Hand-assisted laparoscopic versus laparoscopy-assisted D2 radical gastrectomy: a prospective study.

Authors:  JiaQing Gong; YongKuan Cao; YunMing Li; GuoHu Zhang; PeiHong Wang; GuoDe Luo
Journal:  Surg Endosc       Date:  2014-05-31       Impact factor: 4.584

6.  Interleukin-8: A potent promoter of human lymphatic endothelial cell growth in gastric cancer.

Authors:  Jun Shi; Yong-Jin Li; Bing Yan; Pin-Kang Wei
Journal:  Oncol Rep       Date:  2015-04-17       Impact factor: 3.906

7.  Three-step hand-assisted laparoscopic d2 radical gastrectomy for chinese obese patients: a highly efficient and feasible surgical approach.

Authors:  JiaQing Gong; YongKuan Cao; YongHua Wang; GuoHu Zhang; PeiHong Wang; GuoDe Luo
Journal:  J Cancer       Date:  2015-01-01       Impact factor: 4.207

8.  Learning curve and short-term outcomes of modularized LADG for advanced gastric cancer: A retrospective study.

Authors:  Gang Liao; Ziwei Wang; Hui Li; Jiang Min; Jinkun Zhong; Sandrie Mariella; Kun Qian; Wei Zhang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

Review 9.  Seventh tumor-node-metastasis staging of gastric cancer: Five-year follow-up.

Authors:  Stefano Rausei; Laura Ruspi; Federica Galli; Vincenzo Pappalardo; Giuseppe Di Rocco; Francesco Martignoni; Francesco Frattini; Francesca Rovera; Luigi Boni; Gianlorenzo Dionigi
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.